The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Expansion In Market Value Is Forecasted For The Customized Genetic Testing Market Between 2026 And 2030?
The customized genetic testing market has seen rapid expansion in recent years. It is projected to increase from $14.13 billion in 2025 to $16.4 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 16.0%. The growth observed historically can be ascribed to several factors, including heightened awareness of hereditary diseases, the decreasing cost of genetic sequencing, the broadening of clinical genetic counseling services, an increase in the adoption of predictive testing, and the expanding utilization of molecular diagnostics.
The market size for customized genetic testing is predicted to undergo significant growth in the upcoming years. It is expected to expand to $29.5 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 15.8%. This growth during the forecast period is attributable to factors such as the increasing demand for personalized medicine, the rising integration of genomics into routine care, the expansion of preventive healthcare strategies, the growing adoption of precision oncology, and increasing investment in genomic data platforms. Prominent trends observed in this period include the increasing adoption of personalized genetic panels, the growing use of NGS-based customized testing, the expansion of pharmacogenomic applications, the rising demand for targeted risk assessment, and enhanced integration of clinical decision support.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/report/customized-genetic-testing-global-market-report
What Major Factors Are Driving The Customized Genetic Testing Market Forward?
The customized genetic testing market is anticipated to expand due to the rising acceptance of personalized medicine. Personalized medicine is defined as a healthcare strategy where treatments, preventive measures, and medical choices are specifically adapted to each patient’s unique attributes. This growing uptake of personalized medicine stems from advancements in genomics, proteomics, and biomarker identification, facilitating customized therapies aligned with individual genetic profiles, thus boosting the need for specific treatments, better diagnostic tools, and precise healthcare options. Within this transition, customized genetic testing serves a crucial function by offering in-depth genetic data, allowing for accurate disease risk evaluations, focused therapeutic interventions, and proactive health management. As an illustration, the Personalized Medicine Coalition, a US-based nonprofit organization, stated in February 2024 that the United States Food and Drug Administration (FDA) sanctioned 16 novel personalized therapies for rare disease patients in 2023, a significant increase from merely 6 approvals observed in 2022. Consequently, the expanding embrace of personalized medicine is fueling the development of the customized genetic testing market.
How Is The Customized Genetic Testing Market Organized By Segment Classification?
The customized genetic testing market covered in this report is segmented –
1) By Test Type: Predictive Testing, Carrier Testing, Prenatal And Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing
2) By Sample Type: Saliva, Blood, Buccal Swab
3) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray Analysis, Single-Cell Sequencing
4) By Application: Oncology, Cardiovascular Diseases, Neurological Disorders, Metabolic Disorders
5) By End-User: Predictive Testing, Carrier Testing, Prenatal And Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing
Subsegments:
1) By Predictive Testing: Cancer Susceptibility Testing, Neurodegenerative Disorder Testing, Cardiovascular Disease Risk Testing, Metabolic Disorder Risk Testing
2) By Carrier Testing: Cystic Fibrosis Carrier Testing, Sickle Cell Anemia Carrier Testing, Tay–Sachs Disease Carrier Testing, Thalassemia Carrier Testing
3) By Prenatal And Newborn Testing: Non-Invasive Prenatal Testing (NIPT), Newborn Screening Panels, Chorionic Villus Sampling (CVS), Amniocentesis-Based Genetic Testing
4) By Diagnostic Testing: Rare Disease Diagnosis, Oncology Genetic Testing, Neurological Disorder Diagnosis, Infectious Disease-Associated Genetic Testing
5) By Pharmacogenomic Testing: Drug Metabolism Testing, Oncology Pharmacogenomics, Cardiovascular Drug Response Testing, Psychiatric Drug Response Testing
Which Trends Are Impacting The Progress Of The Customized Genetic Testing Market?
Major companies operating in the customized genetic testing market are increasingly emphasizing direct-to-consumer solutions, particularly at-home DNA testing combined with tailored health plans derived from individual genetic profiles. At-home DNA testing is a type of genetic test that individuals can perform outside of a clinical setting, usually by ordering a kit online or from a pharmacy, collecting a saliva or cheek swab sample at home, and then mailing it to a laboratory for analysis. For instance, in May 2025, Hydreight Technologies Inc., a Canada-based digital health technology company, introduced a personalized genetic testing and wellness solution on its VSDHOne Platform. The service offers patients convenient access to at-home DNA testing kits and provides customized health plans addressing nutrition, fitness, supplementation, and medication compatibility. Additionally, the platform ensures continuity of care through integrated telehealth services and in-person consultations delivered by licensed healthcare professionals.
Who Are The Industry Participants Involved In The Customized Genetic Testing Market?
Major companies operating in the customized genetic testing market are Guardant Health, Tempus, Invitae, 23andMe, Labcorp, Quest Diagnostics, Revvity Omics (PerkinElmer Genomics), Natera, Myriad Genetics, BGI Genomics, CENTOGENE, Veracyte, Fulgent Genetics, LetsGetChecked, Helix, MedGenome, Baylor Genetics, Prenetics, Eurofins (Clinical Genetics), Mapmygenome, Nebula Genomics
Get The Full Customized Genetic Testing Market Report:
https://www.thebusinessresearchcompany.com/report/customized-genetic-testing-global-market-report
Where Is The Customized Genetic Testing Market Primarily Concentrated By Region?
North America was the largest region in the customized genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the customized genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Customized Genetic Testing Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/customized-genetic-testing-global-market-report
Browse Through More Reports Similar to the Global Customized Genetic Testing Market 2026, By The Business Research Company
Genetic Toxicology Testing Market Report 2026
https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report
Genetic Testing Services Market Report 2026
https://www.thebusinessresearchcompany.com/report/genetic-testing-services-global-market-report
Direct To Consumer Dtc Genetic Testing Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
